Literature DB >> 31189824

[A Case of Duodenal Perforation during Bevacizumab Combination Chemotherapy in a Patient with Multiple Lung Metastasis after a Sigmoidectomy].

Hirofumi Suzumura1, Hiroharu Shinozaki, Rie Kondo, Masatoshi Yamaguchi, Yukiko Torizaki, Yosuke Ozawa, Yurie Futoh, Tadashi Matsuoka, Kenji Matsumoto, Masazumi Inoue, Yuichi Sasakura, Toshiaki Terauchi, Masaru Kimata, Junji Furukawa, Kenji Kobayashi, Yoshiro Ogata.   

Abstract

A 73-year-old man underwent laparoscopic sigmoidectomy for sigmoid colon cancer. Two years after the operation, multiple lung metastasis was diagnosed and chemotherapy with bevacizumab, irinotecan, and TS-1®was started in the patient. However, epigastric pain developed 73 days after the initial course of chemotherapy. Abdominal CT revealed duodenal perforation and generalized peritonitis. Emergency operation with omental patch closure was immediately performed. The patient was discharged 15 days after the emergency operation without any complication. This is an extremely rare case of bevacizu- mab-related duodenal perforation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31189824

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Spontaneous massive duodenal perforation after ovarian cancer treatment with bevacizumab.

Authors:  Michael Karanikas; Konstantinia Kofina; Dimitrios Potolidis; Soultana Foutzitzi; Savas Deftereos; Eleni Effraemidou; Nikolaos Lyratzopoulos
Journal:  J Surg Case Rep       Date:  2020-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.